EMVision Prepares to Add Acute Ischemia Detection Endpoint to Brain Scanner Validation Trial; Shares Up 8%
() -- EMVision Medical Devices (ASX:EMV) is advancing preparations to add an acute ischemia detection endpoint to its pivotal validation trial for its point-of-care brain scanning device, with US Food and Drug Administration (FDA) meeting and protocol amendment planned, according to a Wednesday Australian bourse filing